Toxic Epidermal Necrolysis (TEN):
Toxic Epidermal Necrolysis (TEN) is a rare, life-threatening skin disorder in which large areas of skin and mucous membranes blister and peel away.
Symptoms:
· Flu-like symptoms including fever, fatigue, and body aches.
· Rapidly spreading red or painful skin rash.
· Large blisters and sheets of skin peeling away.
· Painful open skin areas.
· Mouth, eye, throat, or genital involvement.
· Light sensitivity and eye irritation.
· Difficulty swallowing, urinating, or breathing in severe cases.
Causes: Most cases of TEN are caused by severe adverse reactions to medications.
· Medication reactions: Common triggers include certain antibiotics, anticonvulsants, non-steroidal anti-inflammatory drugs, allopurinol, and antiretroviral medications.
· Infection-associated triggers: Infections may rarely trigger TEN, particularly in individuals with immune system abnormalities.
· Genetic and immune risk factors: Genetic susceptibility and immune system variations may increase the risk of severe drug reactions leading to TEN.
Diagnosis and Tests: Diagnosis is based on clinical evaluation, medication history review, and physical examination of blistering and peeling skin. A skin biopsy may confirm full-thickness epidermal necrosis. Laboratory testing helps assess dehydration, infection risk, and organ involvement.
Management and Treatment: TEN is a medical emergency that requires hospitalization, often in a burn unit or intensive care setting.
· Immediate measures: The suspected triggering medication must be stopped immediately. Fluid replacement, wound care, infection prevention, and pain management are essential.
· Supportive care: Care focuses on maintaining body temperature, nutrition, and organ function.
· Immune-modulating treatments: Selected patients may receive therapies such as corticosteroids, intravenous immunoglobulin, or cyclosporine based on clinical judgment.
Prognosis: TEN carries significant risk of complications including infection, dehydration, and organ failure. Mortality rates vary depending on severity and patient factors. Survivors may experience long-term complications affecting the skin, eyes, and mucous membranes.
Prevention: Prevention focuses on avoiding known medication triggers and seeking immediate care if rash or flu-like symptoms develop after starting a new drug.
When Should I See My Healthcare Provider? Seek immediate medical attention if you develop a rapidly spreading rash, blistering skin, or painful mucosal lesions.
When Should I Go to the Emergency Room? Go to the emergency room immediately for large areas of skin peeling, severe pain, difficulty breathing, or rapid symptom progression.
What Questions Should I Ask My Healthcare Provider?
· Could this be Toxic Epidermal Necrolysis?
· What medication may have triggered this reaction?
· What treatments are required?
· What complications should be monitored?
· What follow-up care is needed after recovery?
Key Takeaways:
· Toxic Epidermal Necrolysis is a rare and life-threatening skin condition.
· Most cases are caused by severe medication reactions.
· Immediate hospitalization is required.
· Early diagnosis and supportive care improve survival.
· Long-term complications may occur even after recovery.